DISCOVER: Phase III Study of Emtricitabine/Tenofovir Alafenamide vs Emtricitabine/Tenofovir Disoproxil Fumarate for HIV PrEP

March 4-7, 2019; Seattle, Washington
Daily oral PrEP with FTC/TAF is noninferior to FTC/TDF in preventing HIV infection in cis-MSM and transgender women at high risk for HIV acquisition.
Format: Microsoft PowerPoint (.ppt)
File Size: 181 KB
Released: March 11, 2019

Acknowledgements

Directly provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

This program is supported by independent educational grants from
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Related Content

Michelle Sherman, RPh, FASCP, FACA, AAHIVP, discusses how pharmacists can improve HIV care outcomes through testing, prevention, and MTM services

Michelle J. Sherman, RPh, FASCP, FACA, AAHIVP Released: August 20, 2019

Downloadable audio from Jürgen K. Rockstroh, MD, with analysis of key new HIV data from IAS 2019 on NTD risk in pregnancy, PrEP, and emerging ART options

Jürgen K. Rockstroh, MD Released: August 20, 2019

Rapid ART initiation for HIV, practical examples from San Francisco and New Orleans, with Monica Gandhi and Jason Halperin. From Clinical Care Options

Monica Gandhi, MD, MPH Jason Halperin, MD, MPH Released: August 19, 2019

CCO downloadable slides on new HIV data from IAS 2019: PrEP, first-line and switch options, NTD risk with ART at conception, and investigational drugs

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Paul E. Sax, MD
Released: August 15, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?